GLP-1s often seem to be under the purview of endocrinologists, weight management specialists or primary care providers. In one camp, we hear from gastroenterologists who subspecialize in obesity and feel we should fully embrace this drug class and be comfortable prescribing them.
How GLP-1 Drugs Are Used in Pediatric Weight Management. According to the Global Obesity Observatory, the United States has the tenth-highest obesity rate in the world.Doctors are increasingly prescribing these medications to children and teens struggling with obesity.
Nonetheless, as GLP-1 RAs are increasingly prescribed across a wide range of populations, concerns have arisen regarding their long-term safetyparticularly in relation to pancreatic health.
Nephrologists are increasingly integrating functional medicine labs into their practice, using this approach to offer more comprehensive care for patients with kidney disease.
Endocrinologists, diabetologists, cardiologists, and nephrologists are increasingly prescribing them to overweight patients to improve heart and kidney outcomes - for instance, those preparing for angioplasty or stenting.
Such details provide a deeper understanding and appreciation for Nephrologists Are Increasingly Prescribing Glp.
Nephrologists are urged to prescribe GLP-1 receptor agonists for comprehensive cardiovascular risk management in CKD patients.13:30 - Mechanism Behind Lower Infection Risk. 15:30 - Future of Kidney Disease Research. 17:30 - Nephrologists Responsibility to Prescribe GLP-1s.
